Desonide Ointment
Product Images NDC 45802-423

3 FDA label images from Padagis Israel Pharmaceuticals Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Desonide (NDC 45802-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1f1rc Desonide Ointment

1f1rc Desonide Ointment
Packaging label for Desonide Ointment 0.05%, topical ointment in a 15 g tube, distributed by Perrigo and labeled with NDC 45802-423-35. The label includes instructions for external use, storage conditions, and directions for puncturing the tube seal. The labeler is Padagis Israel Pharmaceuticals Ltd.*
FDA Label Image

Perrigo Desonide Ointment (Image 01)

Perrigo Desonide Ointment (Image 01)
Chemical structure diagram of desonide, showing its steroid backbone with multiple rings, hydroxyl group, ketone group, and ester functional groups.*
FDA Label Image

Serialization Template

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.